Cite
HARVARD Citation
Darwish, I. et al. (2022). Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism. Clinical and applied thrombosis/hemostasis. p. . [Online].